Theresa Rosario-Jansen

Title: Innovations by Theresa Rosario-Jansen

Introduction

Theresa Rosario-Jansen is a notable inventor based in Randolph, NJ (US). She has made significant contributions to the field of medical technology, particularly in the area of gout treatment. With a total of seven patents to her name, her work focuses on improving patient outcomes through innovative methods and kits.

Latest Patents

Theresa's latest patents include methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy. These patents specifically address the needs of gout patients undergoing intravenous PEGylated uricase therapy. Routine serum uric acid monitoring can help identify patients who may no longer benefit from treatment and who are at greater risk for infusion reactions.

Career Highlights

Throughout her career, Theresa has worked with prominent companies in the pharmaceutical industry, including Horizon Therapeutics USA, Inc. and Horizon Pharma Rheumatology LLC. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in patient care.

Collaborations

Theresa has collaborated with various professionals in her field, including her coworker David Erick Wright. These partnerships have facilitated the exchange of ideas and expertise, further enhancing her contributions to medical technology.

Conclusion

Theresa Rosario-Jansen's work exemplifies the impact of innovation in healthcare. Her patents and career achievements highlight her dedication to improving treatment options for gout patients. Through her efforts, she continues to pave the way for advancements in medical technology.